4-Methoxy-N-methyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)benzamide

Catalog No. :
ACHHDS537
CAS No. :
866134-21-6
Molecular Formula :
C16H18N2O2S
Molecular Weight :
302.40

IUPAC Name:4-methoxy-N-methyl-N-(4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)benzamide

4-Methoxy-N-methyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methoxy-N-methyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)benzamide
IUPAC Name4-methoxy-N-methyl-N-(4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)benzamide
MDL No.MFCD03848704
Molecular FormulaC16H18N2O2S
Molecular Weight302.40
SMILESO=C(N(C)C1=NC(CCCC2)=C2S1)C3=CC=C(OC)C=C3
InChI KeyUJZAJEOWDWWTOC-UHFFFAOYSA-N
Synonym4-METHOXY-N-METHYL-N-(4,5,6,7-TETRAHYDRO-1,3-BENZOTHIAZOL-2-YL)BENZENECARBOXAMIDE;4-methoxy-N-methyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)benzamide;Benzamide, 4-methoxy-N-methyl-N-(4,5,6,7-tetrahydro-2-benzothiazolyl)-
CAS No.866134-21-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHHDS537 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHHDS537 route product structure diagram
    ACHHDS537866134-21-6
Inquiry

2. ACHHDS537 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYAYZ126 route compound structure diagram
    ACYAYZ12640534-18-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHHDS537 route product structure diagram
    ACHHDS537866134-21-6
Inquiry

Comments (0)